Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence - sprookjes - yvandenbroek - TriplyDB

Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence

Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence

http://www.wikidata.org/entity/Q30862390

about

Ig Constant Region Effects on Variable Region Structure and Function Optimizing Outcomes in Immunocompromised Hosts: Understanding the Role of Immunotherapy in Invasive Fungal Diseases Host immunity to Cryptococcus neoformans Progress toward a Staphylococcus aureus vaccine Development of a vaccine against Staphylococcus aureus Sensitivity of Aspergillus nidulans to the cellulose synthase inhibitor dichlobenil: insights from wall-related genes' expression and ultrastructural hyphal morphologies Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis The Structural Basis of Antibody-Antigen Recognition Differential effects of serum heat treatment on chemotaxis and phagocytosis by human neutrophils.Therapy of murine pulmonary aspergillosis with antibody-alliinase conjugates and alliin.Influence of mannan and glucan on complement activation and C3 binding by Candida albicans.Immunity against fungi.Generation of Recombinant Antibodies against the beta-(1,6)-Branched beta-(1,3)-D-Glucan Schizophyllan from Immunized Mice via Phage Display.Candida infections and their prevention.Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivo The MP65 gene is required for cell wall integrity, adherence to epithelial cells and biofilm formation in Candida albicans Characterizing the role of cell-wall β-1,3-exoglucanase Xog1p in Candida albicans adhesion by the human antimicrobial peptide LL-37.Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus.TLR9 signaling is required for generation of the adaptive immune protection in Cryptococcus neoformans-infected lungs.Persistence versus escape: Aspergillus terreus and Aspergillus fumigatus employ different strategies during interactions with macrophages.Fungal vaccines and immunotherapeutics.Prospects for development of a vaccine to prevent and control vaginal candidiasis.Radiolabeled antibodies for therapy of infectious diseases.CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccine.C. albicans increases cell wall mannoprotein, but not mannan, in response to blood, serum and cultivation at physiological temperature Adaptive immunity to fungi.Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis Toward developing a universal treatment for fungal disease using radioimmunotherapy targeting common fungal antigens Antibodies generated against Streptococci protect in a mouse model of disseminated aspergillosis.Epithelial cells and innate antifungal defense.A Murine, Bispecific Monoclonal Antibody Simultaneously Recognizing β-Glucan and MP65 Determinants in Candida Species.Immunoglobulin isotype influences affinity and specificity.New approaches in the development of a vaccine for mucosal candidiasis: progress and challenges Recent progress in vaccines against fungal diseases Protective Effector Cells of the Recombinant Asp f3 Anti-Aspergillosis Vaccine.Synthesis and immunological studies of linear oligosaccharides of β-glucan as antigens for antifungal vaccine development Molecular characterization of the early B cell response to pulmonary Cryptococcus neoformans infection.A new synthesis for antibody-mediated immunity.Adjuvanticity of a recombinant calreticulin fragment in assisting anti-β-glucan IgG responses in T cell-deficient mice.Potential of anti-Candida antibodies in immunoprophylaxis.

P2860

Q26766449-214430B1-D51D-4A71-8430-84687D74EF7C Q26774692-E01E01A9-EBAF-45E6-A346-10E95B8378E2 Q26823438-21A42872-C891-4CD9-8711-78283263819A Q26829702-74E4A8DE-9001-4C96-B531-29C92950783B Q27015365-36144CF3-F3E5-4ECB-AB33-997D73FF3325 Q28535480-1EB7C1E4-8675-489C-A442-03827A102B64 Q28744094-E2938336-B9F9-42D3-87BA-E75A4B877FA5 Q28972262-1CEE69F1-24A8-46EC-81B9-A9865F8E4120 Q30458909-122AF130-E42B-4B04-9523-E88D81DD510B Q33613647-67D43DE9-888F-46B8-A4BE-688A3F8A58FB Q33675896-86848255-06CB-4A26-A31F-5FF58DA6F0C3 Q33752362-F38EBDC2-2562-41C8-8BCF-D5016D51BF0F Q33768092-75FD96C7-D809-40DC-8DBE-1457E7C5C984 Q33775256-D582878E-72AC-43F5-9FD9-DCE5CBF002E8 Q33825652-191F7B06-5C31-410E-A341-1CEB0CE3F88F Q33901438-7ED5130B-FF20-4CFA-A8D3-6B63F52BEFB1 Q33945417-BE707714-B769-456E-A7AB-4CF89CC84C68 Q33983074-78C196D2-A0A2-410D-95E9-99F6EC4EAF9C Q34033551-226328D7-E81E-4A8A-A7E3-94D7E42263C7 Q34154790-BD2913FA-FAEF-4D78-A4A8-827D5F43DC24 Q34400249-600A3269-A8E8-4257-A923-32962D1D0E5F Q34707478-6657ED31-2E13-4635-829E-A0D91C0AF918 Q34955947-656F27B3-E262-48BE-A25E-15BE78F81468 Q35075750-A7FC7CD4-3F92-47D8-BC78-C99470505E40 Q35147041-A94A5730-8803-4E34-9F53-B7DEF58207CB Q35164257-937457F6-9D68-4E47-9BA8-E89E235CABEE Q35271053-1CA79956-090E-466D-A47E-4CD3F65590A7 Q35422542-B919AC21-D720-4CE8-AD38-60AF26724A4D Q35472340-18FD10DD-ED13-46FC-A614-730764C74847 Q35866679-8204D0EC-850B-429B-877D-848E2C1C6E73 Q35918232-20C06F8B-40C5-4BCD-8EB3-3A359ABD723C Q36140684-CB21153E-BB89-47F3-A329-B1375EC0048C Q36158337-77195410-FA58-4EFF-81E5-6A23293EA0B6 Q36179629-2198AF5B-8F0C-4E62-8F19-7B61A86CEC80 Q36231936-2113E8BB-965F-4350-BBE3-21E28D78B79C Q36331649-EF3CB615-6832-450E-9A0D-8974296C5333 Q36456615-41EC6B12-63D0-4464-9042-CBFE955612F7 Q36660720-35AFEC51-CDDF-4AF5-8A14-2DB0BB306EFA Q36757877-E9263B2F-B1C5-46B1-9133-3D6F04ECA918 Q37773252-80432979-26C0-47A5-9A84-0EC98E1D3131

P2860

Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence

http://www.wikidata.org/entity/Q30862390

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Protection by anti-beta-glucan ...... of fungal growth and adherence

@ast

Protection by anti-beta-glucan ...... of fungal growth and adherence

@en

type

label

Protection by anti-beta-glucan ...... of fungal growth and adherence

@ast

Protection by anti-beta-glucan ...... of fungal growth and adherence

@en

prefLabel

Protection by anti-beta-glucan ...... of fungal growth and adherence

@ast

Protection by anti-beta-glucan ...... of fungal growth and adherence

@en

P1433

Q30862390-00555528-7F00-4427-82C8-71ADAF961515

P1476

Q30862390-F9E955D0-68B2-4584-88B9-D99C8D737C2E

P2093

Q30862390-2BF98CCD-8C3F-44B9-828B-AB94ADB3468B

Q30862390-5B146EE9-077F-4A40-B638-3DCAA4486410

Q30862390-66D018B6-18A2-403A-90D2-F4E9A19131E7

Q30862390-6F3912DB-A2B9-4E33-9450-9F24E69F6E1E

Q30862390-97224B71-4D31-434C-BD7F-AE1FFB5F32B7

Q30862390-A9D7ECBB-A030-44AC-8EA8-1C8133614D18

Q30862390-BD3F6F73-7C05-4100-82C6-2795997872AE

Q30862390-C05A7B58-BE7E-4572-8DC0-1020AE381AE3

Q30862390-C1C68382-BEB4-4DB5-98FB-C690A5395772

P2860

Q30862390-016CE08D-D424-473D-BDF9-C77F6A34523F

Q30862390-026E8E18-3382-498C-9F5B-685BF63A1A66

Q30862390-037F51CC-6885-47B3-B889-070750C9F1CC

Q30862390-03C0E596-20C9-47B1-B07E-2FAB3FE55C57

Q30862390-040D7AFE-F9E6-47F3-9D6A-8ECA34E765CF

Q30862390-0440A6B8-42CA-4A0F-83CE-32046D0CA7E1

Q30862390-09B4AF22-7A14-4381-B5A6-2628AA86E03D

Q30862390-13BEF6C5-2D99-42B9-9FDA-226BE5120216

Q30862390-179D34AF-A322-4F90-A321-AD22DFCC2170

Q30862390-18CF2ADD-08FE-4709-A052-38911DE88683

P304

Q30862390-AF85B890-B148-4566-ACB8-8CCE9BCBFB2E

P31

Q30862390-BFC2FE2B-A638-4235-9E6E-6FDFBBC6D02F

P356

Q30862390-8DDD49A1-97C5-4D09-A05C-8E159A112364

P407

Q30862390-F4C7555A-09BA-4E58-B518-0B3FC9DFA86E

P433

Q30862390-5D3F4A17-F717-48A4-9FCA-2616C8813B1D

P478

Q30862390-85997564-5AAA-4E38-A67F-F5E39A31DD20

P50

Q30862390-3ED8EE1A-1353-423F-BDE8-B5965749097F

Q30862390-53296BAC-924D-4693-805B-813D7E93B7DC

Q30862390-5BC82B85-3420-4869-A57A-256D5A5EC4A1

Q30862390-8857C575-FB02-4B38-AEBE-E09DA25825DB

P577

Q30862390-6D57A10B-C701-483F-939F-6C0A3006FD44

P5875

Q30862390-9DB4C637-1AB9-4E73-855A-C0FE5613AABB

P698

Q30862390-172A0B8B-0D35-4418-BAAD-EE4E78EEC4C5

P921

Q30862390-C2FA397D-1E9C-4869-A9EA-63631AA5490B

P932

Q30862390-D98962AA-86C8-4189-ABDF-C7FFDF9F7C21

P356

JOURNAL.PONE.0005392

P1433

P1476

Protection by anti-beta-glucan ...... of fungal growth and adherence

@en

P2093

Angelina S Palma

http://www.w3.org/2001/XMLSchema#string

Antonio Cassone

http://www.w3.org/2001/XMLSchema#string

Bruno Maras

http://www.w3.org/2001/XMLSchema#string

Carla Bromuro

http://www.w3.org/2001/XMLSchema#string

Flavia De Bernardis

http://www.w3.org/2001/XMLSchema#string

Giuseppina Mignogna

http://www.w3.org/2001/XMLSchema#string

Paola Chiani

http://www.w3.org/2001/XMLSchema#string

Silvia Zamboni

http://www.w3.org/2001/XMLSchema#string

Yan Liu

http://www.w3.org/2001/XMLSchema#string

P2860

A drug-sensitive genetic network masks fungi from the immune system

The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus

Characterization of agglutinin-like sequence genes from non-albicans Candida and phylogenetic analysis of the ALS family

Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment

Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis.

Fungicidal monoclonal antibody C7 binds to Candida albicans Als3.

Gene overexpression/suppression analysis of candidate virulence factors of Candida albicans.

the hyphal-associated adhesin and invasin Als3 of Candida albicans mediates iron acquisition from host ferritin

Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice

A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.

P304

e5392

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0005392

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Annarita Stringaro

Antonella Torosantucci

P577

2009-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24366221

http://www.w3.org/2001/XMLSchema#string

P698

19399183

http://www.w3.org/2001/XMLSchema#string

P921

P932

2670538

http://www.w3.org/2001/XMLSchema#string